Torthaí cuardaigh - Puyuan Xing

  • 1 - 3 toradh as 3 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Íomhá chlúdaigh

    ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer de réir Dantong Sun, Fei Teng, Puyuan Xing, Junling Li

    Foilsithe / Cruthaithe 2021
    Connect to this object online.
    LEABHAR

    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Íomhá chlúdaigh

    EGFR uncommon alterations in advanced non-small cell lung cancer and structural insights into sensitivity to diverse tyrosine kinase inhibitors de réir Haiyan Xu, Guangjian Yang, Runze Liu, Yaning Yang, Weihua Li, Junling Li, Xuezhi Hao, Puyuan Xing, Yan Wang

    Foilsithe / Cruthaithe 2022
    Connect to this object online.
    LEABHAR

    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Íomhá chlúdaigh

    Multi-dimensional characterization of immunological profiles in small cell lung cancer uncovers clinically relevant immune subtypes with distinct prognoses and therapeutic vulnerab... de réir Lin Yang, Zicheng Zhang, Jiyan Dong, Yibo Zhang, Zijian Yang, Yiying Guo, Xujie Sun, Junling Li, Puyuan Xing, Jianming Ying, Meng Zhou

    Foilsithe / Cruthaithe 2023
    Connect to this object online.
    LEABHAR

    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: